Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study

Introduction: Immunization of patients with chronic lymphocytic leukemia (CLL) with vaccines against several infectious diseases has proven insufficient. Data on seroconversion of patients with CLL after vaccination against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) are still young...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Panagiotis T. Diamantopoulos, Christos Stafylidis, Dimitra Vlachopoulou, Christina-Nefeli Kontandreopoulou, Nefeli Giannakopoulou, Maria Vardaka, Anthi Mpouhla, Elpida Mastrogianni, Eleni Variami, Athanasios Galanopoulos, Vasiliki Pappa, Mina Psichogiou, Angelos Hatzakis, Nora-Athina Viniou
Format: Artigo
Langue:Inglês
Publié: SAGE Publishing 2022-05-01
Collection:Therapeutic Advances in Hematology
Accès en ligne:https://doi.org/10.1177/20406207221090150
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires